Last $2.18 USD
Change Today +0.03 / 1.40%
Volume 29.4K
BLFS On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ CM
As of 8:10 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

biolife solutions inc (BLFS) Snapshot

Open
$2.19
Previous Close
$2.15
Day High
$2.19
Day Low
$2.15
52 Week High
10/25/13 - $23.94
52 Week Low
06/26/14 - $1.75
Market Cap
26.2M
Average Volume 10 Days
32.1K
EPS TTM
$-0.33
Shares Outstanding
12.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for BIOLIFE SOLUTIONS INC (BLFS)

Related News

No related news articles were found.

biolife solutions inc (BLFS) Related Businessweek News

No Related Businessweek News Found

biolife solutions inc (BLFS) Details

BioLife Solutions, Inc. develops, manufactures, and markets patented hypothermic storage and cryopreservation solutions for cells and tissues. The company’s products are serum-free and protein-free solutions, which are formulated to reduce preservation-induced, delayed-onset cell damage, and death. Its HypoThermosol series of products include HypoThermosol FRS, a solution formulated to decrease the free radical accumulation in cells undergoing prolonged hypothermic preservation; and PrepaStor, a flush solution designed for use during the transitions from normothermic to mild hypothermic conditions to rinse culture media and native fluids from tissue and whole organ systems prior to suspension in a preservation solution. The company’s CryoStor series of products consist of CryoStor CS2, CryoStor CS5, and CryoStor CS10, which are cryopreservation freeze media products designed to mitigate temperature-induced molecular cell stress responses during freezing and thawing. Its BloodStor products comprise BloodStor 55-5 and BloodStor 100 that are biopreservation media products designed for cryopreservation of cells isolated from umbilical cord blood, peripheral blood, and bone marrow. The company also provides SAVSU range of precision thermal packaging products; custom product formulation and custom packaging services; and contract aseptic manufacturing formulation, fill, and finish services of liquid media products. It markets its products to the biobanking, drug discovery, and regenerative medicine markets, including hospital-based stem cell transplant centers, pharmaceutical companies, cord blood and adult stem cell banks, hair transplant centers, and suppliers of cells to the drug discovery, toxicology testing, and diagnostic markets. BioLife Solutions, Inc. was founded in 1987 and is based in Bothell, Washington.

23 Employees
Last Reported Date: 03/21/14
Founded in 1987

biolife solutions inc (BLFS) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $450.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $213.8K
Chairman of Scientific Advisory Board, Chief ...
Total Annual Compensation: $239.8K
Compensation as of Fiscal Year 2013.

biolife solutions inc (BLFS) Key Developments

BioLife Solutions, Inc. Presents at Aegis Capital 2014 Healthcare & Technology Conference, Sep-11-2014 02:00 PM

BioLife Solutions, Inc. Presents at Aegis Capital 2014 Healthcare & Technology Conference, Sep-11-2014 02:00 PM. Venue: The Encore at Wynn Las Vegas, 3121 Las Vegas Blvd. South, Las Vegas, NV 89109, United States. Speakers: Mike Rice, CEO.

BioLife Solutions, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

BioLife Solutions, Inc. reported earnings results for the second quarter and six months ended June 30, 2014. For the quarter, total revenue was $1,211,900 against $2,330,018 a year ago. Operating loss was $887,873 against $82,844 a year ago. Net loss was $883,356 or $0.07 per basic and diluted share against $282,506 or $0.06 per basic and diluted share a year ago. For the six months, total revenue was $3,276,930 against $4,490,030 a year ago. Operating loss was $1,256,914 against operating income of $109,487 a year ago. Net loss was $1,442,727 or $0.16 per basic and diluted share against $289,682 or $0.06 per basic and diluted share a year ago. Cash provided by operating activities was $1,767,644 against $79,992 a year ago.

BioLife Solutions, Inc. to Report Q2, 2014 Results on Aug 07, 2014

BioLife Solutions, Inc. announced that they will report Q2, 2014 results at 10:00 AM, GMT Standard Time on Aug 07, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BLFS:US $2.18 USD +0.03

BLFS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Sigma-Aldrich Corp $102.37 USD -0.93
View Industry Companies
 

Industry Analysis

BLFS

Industry Average

Valuation BLFS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.4x
Price/Book 2.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOLIFE SOLUTIONS INC, please visit www.biolifesolutions.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.